Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...

By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...

India, with over 101 million diabetes patients and rising obesity rates, faces a critical need for effective treatment ...

The Supreme Court last year blocked a previous settlement proposal from Purdue, arguing that the plan would afford the ...

Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, outpacing competitor Novo Nordisk. With ...

Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...

With the growing demand for weight-loss solutions, many individuals in India have resorted to purchasing obesity drugs from ...

Shares of OptiNose (NASDAQ:OPTN) climbed ~61% in the premarket on Thursday after the specialty pharmaceutical company agreed ...

Talks of a trade dispute between the United States and Australia over the cost of medicines have no doubt left many Australians scratching their heads. With all this talk of attacks on the ...

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

Here is what senior living operators need to know about the risks and actions they must take to guard against at-risk residents slipping through the cracks.

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...